Participant flow

Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant · Source last updated 2023-10-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Pentostatin to be administered intravenously on days -10, -9, and -8 at a dose of 4mg/m2/day

   id

   FG000

   title

   Cohort I

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         2

      type

      Withdrawal by Subject

   2. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      psychiatric instability

   3. reasons

      1. group Id

         FG000

         num Subjects

         5

      type

      Adverse Event

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         76

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         68

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         8

      type

      NOT COMPLETED

   title

   Overall Study

recruitment Details

Between November 2001 and February 2007 sixty eight patients were treated on this protocol and have been included in the analysis

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice